## **Core Concept**
Allergic Bronchopulmonary Aspergillosis (ABPA) is a hypersensitivity reaction to *Aspergillus* species, commonly seen in patients with asthma or cystic fibrosis. This condition results from an allergic inflammatory response to the presence of *Aspergillus* antigens in the airways. The primary organism implicated in ABPA is *Aspergillus fumigatus*.

## **Why the Correct Answer is Right**
The correct answer, *Aspergillus fumigatus*, is the organism most frequently associated with ABPA. This fungus is ubiquitous in the environment and can colonize the airways of susceptible individuals, triggering an allergic response. The immune response to *Aspergillus fumigatus* involves the production of IgE antibodies and the activation of eosinophils, leading to airway inflammation and symptoms characteristic of ABPA, such as wheezing, coughing, and bronchiectasis.

## **Why Each Wrong Option is Incorrect**
- **Option A:** While other species of *Aspergillus*, such as *Aspergillus flavus* and *Aspergillus terreus*, can also cause infections and allergic reactions, they are less commonly associated with ABPA compared to *Aspergillus fumigatus*.
- **Option B:** This option is blank and does not provide a viable alternative.
- **Option C:** Similarly, this option is blank and does not offer a credible alternative.

## **Clinical Pearl / High-Yield Fact**
A key clinical pearl is that ABPA should be suspected in patients with asthma or cystic fibrosis who present with worsening respiratory symptoms, particularly if they have a history of bronchiectasis or recurrent pulmonary infiltrates. The presence of high levels of total IgE and *Aspergillus*-specific IgE antibodies supports the diagnosis.

## **Correct Answer:** .